Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel A Funt

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell TumorsSamuel A Funt, Sujata Patil, Darren R Feldman, et al.
Urology|December 7, 2025
Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p AssayJonathan Huynh, Adam Levin, Vincent D'Andrea, et al.
Cell Reports|April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive ClassesAlexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
European Urology Open Science|August 18, 2025
Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell TumorsViranda H Jayalath, Fady Baky, Samuel A Gold, et al.
The Journal of Molecular Diagnostics : JMD|August 7, 2022
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory SettingFei Ye, Darren R Feldman, Alisa Valentino, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 2011
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient miceMeena S Madhur, Samuel A Funt, Li Li, et al.
Urology|August 11, 2024
Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell TumorsFady J Baky, Nicole Liso, Brandon Williams, et al.
Journal of the American Academy of Dermatology|April 8, 2024
Extramammary Paget disease. Part II. Evidence-based approach to managementRohan R Shah, Kalee Shah, Britney N Wilson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 3, 2021
Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint InhibitorsJose Mauricio Mota, Min Yuen Teo, Karissa Whiting, et al.
BJU International|January 10, 2025
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumoursFady Baky, Richard S Matulewicz, Andrea Knezevic, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell TumorsSamuel A Funt, Sujata Patil, Darren R Feldman, et al.
Urology|December 7, 2025
Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p AssayJonathan Huynh, Adam Levin, Vincent D'Andrea, et al.
Cell Reports|April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive ClassesAlexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
European Urology Open Science|August 18, 2025
Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell TumorsViranda H Jayalath, Fady Baky, Samuel A Gold, et al.
The Journal of Molecular Diagnostics : JMD|August 7, 2022
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory SettingFei Ye, Darren R Feldman, Alisa Valentino, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 2011
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient miceMeena S Madhur, Samuel A Funt, Li Li, et al.
Urology|August 11, 2024
Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell TumorsFady J Baky, Nicole Liso, Brandon Williams, et al.
Journal of the American Academy of Dermatology|April 8, 2024
Extramammary Paget disease. Part II. Evidence-based approach to managementRohan R Shah, Kalee Shah, Britney N Wilson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 3, 2021
Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint InhibitorsJose Mauricio Mota, Min Yuen Teo, Karissa Whiting, et al.
BJU International|January 10, 2025
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumoursFady Baky, Richard S Matulewicz, Andrea Knezevic, et al.
Pageof 8